Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-2206 in KRAS-WT/PIK3CA-Mutated Metastatic Colorectal Cancer
NCT01186705Phase 2Terminated
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MK-2206 in colorectal cancer (CRC), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2010; status: terminated.
02
Drugs
MK-2206
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01186705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01186705.